Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × durvalumab × Gynecologic × Clear all

Phase

Status

Completed 14 Active not recruiting 10 Unknown 6 Recruiting 5 Terminated 4 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 11 Thoracic 9 Genitourinary 2 Gynecologic 1

Conditions

Ovarian Neoplasms 1

Interventions

Paclitaxel 20 Carboplatin 13 Cisplatin 11 Bevacizumab 9 pembrolizumab 6 fluzoparib 6 Drug Therapy 6 Brachytherapy 6 apatinib 5 Radiotherapy 5 Injections 5 lenvatinib 4 famitinib 4 Topotecan 4 Tirzepatide 4 Platinum 4 Observation 4 Neoadjuvant Therapy 4 olaparib 3 envafolimab 3 dostarlimab 3 camrelizumab 3 Platinum Compounds 3 zimberelimab 2 toripalimab 2 tislelizumab 2 sintilimab 2 niraparib 2 fludarabine 2 Watchful Waiting 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06650709 2024-10-23

NEOCATS

British Columbia Cancer Agency

Phase 2 Not yet recruiting

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡